Table 2.

Pre-test and change in anxiety symptoms over the study (intention-to-treat sample)

Assessment	MindLight	CBT	Mean differencea	SD	95% CI
Total child
Pre-test	0.98	0.99
Post-test–pre-testb	− 0.24	− 0.24	0.01	0.34	[− 0.04, 0.06]c
3-month FU–pre-testb	− 0.32	− 0.34	0.02	0.42	[− 0.04, 0.08]c
6-month FU–pre-testb	− 0.40	− 0.36	− 0.05	0.42	[− 0.11, 0.02]c
n	82	83
Personalized child
Pre-test	0.98	0.99
Post-test–pre-testb	− 0.31	− 0.20	− 0.12	0.47	[− 0.19, − 0.04]d
3-month FU–pre-testb	− 0.41	− 0.38	− 0.04	0.54	[− 0.12, 0.05]c
6-month FU–pre-testb	− 0.52	− 0.37	− 0.15	0.56	[− 0.23, − 0.06]d
n	82	83
Total mother
Pre-test	0.51	0.50
Post-test–pre-testb	− 0.09	− 0.09	− 0.01	0.17	[− 0.03, 0.02]c
3-month FU–pre-testb	− 0.12	− 0.13	0.01	0.17	[− 0.01, 0.04]c
6-month FU–pre-testb	− 0.14	− 0.16	0.02	0.20	[− 0.01, 0.05]c
n	80	81
Total father
Pre-test	0.47	0.46
Post-test–pre-testb	− 0.09	− 0.08	− 0.01	0.17	[− 0.04, 0.02]c
3-month FU–pre-testb	− 0.12	− 0.12	0.00	0.17	[− 0.03, 0.03]c
6-month FU–pre-testb	− 0.15	− 0.16	0.01	0.19	[− 0.02, 0.04]c
n	69	69

CI confidence interval

^aA negative difference is a difference in favor of MindLight

^bA negative score means a decrease in the severity of symptoms

^cThe 95% CI of the difference in symptom change lies entirely between the equivalence margins of − 0.16 and + 0.16 points, indicating equivalence of MindLight and CBT

^dThe 95% CI of the difference in symptom change lies entirely to the left of 0, indicating significant differences in favor of MindLight